A study, which was published in The New England Journal of Medicine, found that tirzepatide (Zepbound) is more effective for ...

This one-time weight-loss drug leader has suffered several setbacks lately. It isn't wise to count out this veteran ...

Also: A Medicare crisis and doctors’ concerns with Kennedy’s new coronavirus vaccine policy.

Health experts are raising concerns for women using popular weight loss medications, particularly GLP-1s like Wegovy, ...

Eli Lilly (NYSE: LLY) sells a broad range of medicines, from cancer and immunology drugs to treatments for migraine. Right ...

Joie Armstrong knows that a home-cooked meal featuring whole foods is the best way to get her daily nutrients. She takes cues ...

Ireland previously made the list in 2019 and 2021, but has returned as Donald Trump promises to clamp down on allegedly ...

Here's what the new study can tell us. A study, which was published in The New England Journal of Medicine, found that tirzepatide (Zepbound) is more effective for weight loss in a head-to-head ...

Long Islanders, doctors and industry experts weigh in on medicines like Ozempic and Wegovy — how they work, what they ...

Regeneron isn’t the only Big Pharma to spot potential in Hansoh’s obesity pipeline. Merck & Co. ended last year paying $112 ...